Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans

Abstract

Gregg C. Fonarow, MD; Anthony C. Keech, MD; Terje R. Pedersen, MD; Robert P. Giugliano, MD, SM; Peter S. Sever, PhD, FRCP; Peter Lindgren, PhD; Ben van Hout, PhD; Guillermo Villa, PhD; Yi Qian, PhD; Ransi Somaratne, MD; Marc S. Sabatine, MD, MPH